Pinanong Na Phatthalung1*, Yelena Ginzburg, MD2,3, Gabrielle van Caloen, PhD2*, Marina Planoutene2*, Anisa A. Gumerova, MD, PhD, DSc4*, Ronit Witztum, MD2,4*, Eva Ingber2*, Farhath Sultana, PhD4*, Funda Korkmaz, MD4*, Maayan Levy2*, Tony Yuen, PhD3,4* and Mone Zaidi, MD, PhD3,4*
1Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, AL, Thailand
2Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
3Center of Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY
4The Mount Sinai Bone Program, Departments of Pharmacological Sciences and of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY